TrueNorth Wealth & Impact, LLC’s Amgen AMGN Stock Holding History

TrueNorth Wealth & Impact, LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.32M	Buy	+3,142	New	+$1.25M	0.5%	40

Other funds holding AMGN

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

TrueNorth Wealth & Impact, LLC's AMGN Position: Q3 2026 in Review

TrueNorth Wealth & Impact, LLC opened a new position in Amgen (AMGN) in Q3 2026: 3,142 shares worth $1.32M. The stake represents 0.5% of the portfolio and ranks #40 among its holdings.

2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

TrueNorth Wealth & Impact, LLC held 3,142 shares of Amgen worth $1.32M as of Q3 2026.
Amgen was a new TrueNorth Wealth & Impact, LLC position in Q3 2026.
Amgen made up 0.5% of TrueNorth Wealth & Impact, LLC's portfolio in Q3 2026, its #40 holding.
2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on TrueNorth Wealth & Impact, LLC's 13F filing for Q3 2026, filed 13 Nov 2026.